RT @DrJNaidoo: Great to see our young ones at the ESMO Lung Preceptorship 🫁 🇫🇷 Thanks @myESMO for your commitment to training the next ge…

RT @LouiseDiamond20: Honoured to accept an award at the inaugural HSE Patient Flow Excellence Awards on behalf of the incredible team leadi…

RT @charles_gillham: Another great day for the St Luke’s Radiation Oncology Network as the first patient is treated with liver SABR. A trul…

RT @PTarantinoMD: #INAVO120, which led to the approval of inavolisib for HR+/HER2- MBC, is now published in @NEJM. Strong data, with doubli…

RT @UHW_Waterford: Winners get cake, @DarrenJ_Walsh (hosp pharmacist of the year) Deirdre - Aseptic Services Team rep (finalist) Dr. Ann Ho…

RT @BanerjeeSusana: Thanks to great panel and audience @myESMO #RTF #ESMO24 forum addressing burnout and resilience together. Join us at th…

RT @DrJonLim: Great to hear insights directly from our #ESMORTF expert in Organisational Health & Wellbeing at the ‘Policy & Preventative S…

RT @hoperugo: #ESMO24 Natalee 4 yr update with increasing benefit in all subgroups c/w carryover effect. 36% <3 yrs; 20% due to AEs. 8.6% g…

RT @hoperugo: Peter Schmid presents the OS data from KN522 #ESMO24 publl now in NEJM. >6 year FU: 9% EFS benefit, 5% ⬆️OS with pembro pre/p…

RT @DrJonLim: 🌟 Don't miss out! Apply to come join us in Barcelona 🇪🇸 in 2025 in the *first* dedicated #ESMORTF 2-day interactive worksho…

RT @MGMcNamara: Informative session on CUP #ESMO24 @myESMO @oncocook with recent publication of CUPISCO trial leading to changes in ESMO gu…

ESMO Resilience Task Force Special Session.... sharing the recommendations & panel discussion on next steps

RT @DrJonLim: #YoungOncologists have been recurrently reported to be at high risk of #burnout. 💡Are there any other initiatives/suggestio…

RT @CaulfieldTim: "Patients who subscribe to alternative therapies are twice as likely to die in the same period as those who rely on conve…

RT @JAMAOnc: Half of people with inherited BRCA1/2 mutations are men, yet very few men are offered genetic testing or know the importance t…

RT @DrJonLim: *JUST LAUNCHED* First of its kind ESMO Resilience Task Force special workshop. 🌍 Are you an oncologist working in Europe?…

RT @cancertrials_ie: We're just one week out from the ISMO after ASCO meeting (online). Registered? If not 📩 info@cancertrials.ie Full…

Future of medical oncology in Ireland is bright ✨️ Delighted to present these trainees with their certificates of completion of medial oncology training @RCPI_news

RT @marklewismd: Not every day that you get to celebrate a years-long survival advantage in the treatment of small cell lung cancer!!! Mi…